![Sebastien Ribault](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sebastien Ribault
Corporate Officer/Principal bij OXFORD BIOMEDICA PLC
Profiel
Sebastien Ribault is currently the Chairman at Merck Biodevelopment SAS, Director at Cell-Easy SAS (starting in 2023), and Chief Commercial Officer at Oxford Biomedica Plc (starting in 2022).
Previously, he worked as the Head of Research & Development Laboratory at Hemosystem SA. He obtained a doctorate degree from the University of Strasbourg.
Actieve functies van Sebastien Ribault
Bedrijven | Functie | Begin |
---|---|---|
OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01-01-2022 |
Merck Biodevelopment SAS
![]() Merck Biodevelopment SAS Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Merck Biodevelopment SAS engages in research and development in other physical and natural sciences. The company is based in Lyon, France. The CEO of the French company is Didier Rosenberger. | Voorzitter | - |
Cell-Easy SAS
![]() Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Directeur/Bestuurslid | 11-05-2023 |
Eerdere bekende functies van Sebastien Ribault
Bedrijven | Functie | Einde |
---|---|---|
Hemosystem SA
![]() Hemosystem SA Medical SpecialtiesHealth Technology Hemosystem SA developed technologies to improve safety in the blood transfusion. The company was founded by Jean-Pierre Hermet in May 1999 and was headquartered in Marseille, France. | Corporate Officer/Principal | - |
Opleiding van Sebastien Ribault
University of Strasbourg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OXFORD BIOMEDICA PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Merck Biodevelopment SAS
![]() Merck Biodevelopment SAS Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Merck Biodevelopment SAS engages in research and development in other physical and natural sciences. The company is based in Lyon, France. The CEO of the French company is Didier Rosenberger. | Commercial Services |
Cell-Easy SAS
![]() Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Commercial Services |
Hemosystem SA
![]() Hemosystem SA Medical SpecialtiesHealth Technology Hemosystem SA developed technologies to improve safety in the blood transfusion. The company was founded by Jean-Pierre Hermet in May 1999 and was headquartered in Marseille, France. | Health Technology |